Sign In
Buy PRVB
$24.98
+0 (+0%)
At Close: Jul 24, 2023
NEW YORK, May 25, 2021 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Provention Bio, Inc. ("Proventio
Provention Bio Announces Posting of Briefing Documents for FDA Advisory Committee Meeting on Teplizumab
09:30am, Tuesday, 25'th May 2021
RED BANK, N.J., May 25, 2021 /PRNewswire/ -- Provention Bio, Inc., (Nasdaq: PRVB), a biopharmaceutical company dedicated to intercepting and preventing immune-mediated disease, announced today that t
Implied Volatility Surging for Provention Bio (PRVB) Stock Options
09:01am, Tuesday, 25'th May 2021
Investors need to pay close attention to Provention Bio (PRVB) stock based on the movements in the options market lately.
NEW YORK--(BUSINESS WIRE)-- #Action--Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, announces that a class action lawsuit has been filed in the United States Distric
Notice of Lead Plaintiff Deadline for Shareholders in the Provention Bio, Inc. Class Action Lawsuit
10:40pm, Friday, 21'st May 2021
SAN DIEGO--(BUSINESS WIRE)-- #PRVBstock--The suit alleges defendants issued false statements re: Provention Bio business and prospects, resulting in its stock trading at inflated prices.
Pomerantz Law Firm Announces the Filing of a Class Action Against Provention Bio, Inc. and Certain Officers - PRVB
10:02pm, Friday, 21'st May 2021
NEW YORK, May 21, 2021 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Provention Bio, Inc. ("Provention" or the "Company") (NASDAQ: PRVB) and certain of its
Provention Bio, Inc. (PRVB) CEO Ashleigh Palmer on Q1 2021 Results - Earnings Call Transcript
11:49am, Saturday, 08'th May 2021
Provention Bio, Inc. (PRVB) CEO Ashleigh Palmer on Q1 2021 Results - Earnings Call Transcript
Provention Bio Reports First Quarter 2021 Financial Results and Provides Business Update
07:00am, Thursday, 06'th May 2021
RED BANK, N.J., May 6, 2021 /PRNewswire/ -- Provention Bio, Inc. (Nasdaq: PRVB), a biopharmaceutical company dedicated to intercepting and preventing immune-mediated disease, today reported financial
Provention Bio Announces the Grant of Inducement Awards
05:00pm, Monday, 03'rd May 2021
RED BANK, N.J., May 3, 2021 /PRNewswire/ -- Provention Bio, Inc. (Nasdaq: PRVB) (the "Company"), a biopharmaceutical company dedicated to intercepting and preventing immune-mediated diseases, today an
Provention Bio to Report First Quarter 2021 Financial Results on May 6, 2021
04:00pm, Thursday, 29'th Apr 2021
RED BANK, N.J., April 29, 2021 /PRNewswire/ -- Provention Bio, Inc. (Nasdaq: PRVB), a biopharmaceutical company dedicated to intercepting and preventing immune-mediated disease, today announced that
RED BANK, N.J., April 27, 2021 /PRNewswire/ -- Provention Bio, Inc., (Nasdaq: PRVB), a biopharmaceutical company dedicated to intercepting and preventing immune-mediated disease, today announced the
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Provention Bio, Inc. - PRVB
07:54pm, Wednesday, 21'st Apr 2021
New York, New York--(Newsfile Corp. - April 21, 2021) - Pomerantz LLP is investigating claims on behalf of investors of Provention Bio, Inc. ("Provention" or the "Company") (NASDAQ: PRVB). Such inve
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Provention Bio, Inc. - PRVB
11:17pm, Monday, 19'th Apr 2021
NEW YORK, April 19, 2021 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Provention Bio, Inc. ("Provention" or the "Company") (NASDAQ: PRVB). Such investors are
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Provention Bio, Inc. - PRVB
11:39pm, Tuesday, 13'th Apr 2021
NEW YORK, April 13, 2021 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Provention Bio, Inc. ("Provention" or the "Company") (NASDAQ: PRVB). Such investors are
Are Options Traders Betting on a Big Move in Provention Bio (PRVB) Stock?
09:51am, Monday, 12'th Apr 2021
Investors need to pay close attention to Provention Bio (PRVB) stock based on the movements in the options market lately.
